Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, has announced that the CLINAPAI program coordinated by Quantum Genomics under the scientific supervision of Dr. Catherine Llorens-Cortes (INSERM U1050/Collège of France) and in collaboration with the Clinical Investigation Centre of the European Georges Pompidou Hospital in Paris, has received a research grant of € 1 million allocated by the National Agency of Research (ANR).
